“…The exact mechanisms by which LC n ‐3PUFAs influence muscle protein synthesis, strength, and function are still largely unknown (Ewaschuk, Almasud, & Mazurak, ; Smith et al, , ), but the available evidence suggests it may be multifaceted including anti‐inflammatory actions, direct stimulation of muscle protein synthesis via signal transduction pathways such as the mammalian target of rapamycin (mTOR) pathway and increasing membrane fluidity. LC n ‐3PUFAs possess anti‐inflammatory properties (Fetterman & Zdanowicz, ; H. J. Lee, Jung, Cho, & Hwang, ; K. T. Lee, Akoh, & Dawe, ), which are exerted in both healthy and disease conditions (L. E. Robinson & Mazurak, ), and which are thought to play a role in muscle protein metabolism (Smith et al, ), since muscle loss‐inducing conditions such as cancer, injury, and aging (Casperson, Sheffield‐Moore, Hewlings, & Paddon‐Jones, ; Murphy, Mourtzakis, Chu, Reiman, & Mazurak, ; C. Pereira, Murphy, Jeschke, & Herndon, ) are all linked to heightened inflammatory activity (Degens, ; Jeschke et al, ; McMillan, ; Subramanian et al, ). Specific LC n ‐3PUFAs; eicosapentaenoic acid (EPA, C20:5 n ‐3) and docosahaexaenoic acid (DHA, C22:6 n ‐3) are also suggested to simulate skeletal muscle anabolic processes directly through mediation of the mTORC1‐p70S6K1 signaling pathway (Gingras et al, ; Novak & Innis, ; Smith et al, , ).…”